Stock Analysis on Net
Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Paying user area

Try for free

Allergan Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Allergan Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2014 = ×
Sep 30, 2014 = ×
Jun 30, 2014 = ×
Mar 31, 2014 = ×
Dec 31, 2013 = ×
Sep 30, 2013 = ×
Jun 30, 2013 = ×
Mar 31, 2013 = ×
Dec 31, 2012 = ×
Sep 30, 2012 = ×
Jun 30, 2012 = ×
Mar 31, 2012 = ×
Dec 31, 2011 = ×
Sep 30, 2011 = ×
Jun 30, 2011 = ×
Mar 31, 2011 = ×
Dec 31, 2010 = ×
Sep 30, 2010 = ×
Jun 30, 2010 = ×
Mar 31, 2010 = ×

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q4 2014 is the increase in profitability measured by return on assets ratio (ROA).

Three-Component Disaggregation of ROE

Allergan Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2014 = × ×
Sep 30, 2014 = × ×
Jun 30, 2014 = × ×
Mar 31, 2014 = × ×
Dec 31, 2013 = × ×
Sep 30, 2013 = × ×
Jun 30, 2013 = × ×
Mar 31, 2013 = × ×
Dec 31, 2012 = × ×
Sep 30, 2012 = × ×
Jun 30, 2012 = × ×
Mar 31, 2012 = × ×
Dec 31, 2011 = × ×
Sep 30, 2011 = × ×
Jun 30, 2011 = × ×
Mar 31, 2011 = × ×
Dec 31, 2010 = × ×
Sep 30, 2010 = × ×
Jun 30, 2010 = × ×
Mar 31, 2010 = × ×

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q4 2014 is the increase in profitability measured by net profit margin ratio.

Five-Component Disaggregation of ROE

Allergan Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2014 = × × × ×
Sep 30, 2014 = × × × ×
Jun 30, 2014 = × × × ×
Mar 31, 2014 = × × × ×
Dec 31, 2013 = × × × ×
Sep 30, 2013 = × × × ×
Jun 30, 2013 = × × × ×
Mar 31, 2013 = × × × ×
Dec 31, 2012 = × × × ×
Sep 30, 2012 = × × × ×
Jun 30, 2012 = × × × ×
Mar 31, 2012 = × × × ×
Dec 31, 2011 = × × × ×
Sep 30, 2011 = × × × ×
Jun 30, 2011 = × × × ×
Mar 31, 2011 = × × × ×
Dec 31, 2010 = × × × ×
Sep 30, 2010 = × × × ×
Jun 30, 2010 = × × × ×
Mar 31, 2010 = × × × ×

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q4 2014 is the increase in operating profitability measured by EBIT margin ratio.

Two-Component Disaggregation of ROA

Allergan Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2014 = ×
Sep 30, 2014 = ×
Jun 30, 2014 = ×
Mar 31, 2014 = ×
Dec 31, 2013 = ×
Sep 30, 2013 = ×
Jun 30, 2013 = ×
Mar 31, 2013 = ×
Dec 31, 2012 = ×
Sep 30, 2012 = ×
Jun 30, 2012 = ×
Mar 31, 2012 = ×
Dec 31, 2011 = ×
Sep 30, 2011 = ×
Jun 30, 2011 = ×
Mar 31, 2011 = ×
Dec 31, 2010 = ×
Sep 30, 2010 = ×
Jun 30, 2010 = ×
Mar 31, 2010 = ×

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on assets ratio (ROA) over Q4 2014 is the increase in profitability measured by net profit margin ratio.

Four-Component Disaggregation of ROA

Allergan Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2014 = × × ×
Sep 30, 2014 = × × ×
Jun 30, 2014 = × × ×
Mar 31, 2014 = × × ×
Dec 31, 2013 = × × ×
Sep 30, 2013 = × × ×
Jun 30, 2013 = × × ×
Mar 31, 2013 = × × ×
Dec 31, 2012 = × × ×
Sep 30, 2012 = × × ×
Jun 30, 2012 = × × ×
Mar 31, 2012 = × × ×
Dec 31, 2011 = × × ×
Sep 30, 2011 = × × ×
Jun 30, 2011 = × × ×
Mar 31, 2011 = × × ×
Dec 31, 2010 = × × ×
Sep 30, 2010 = × × ×
Jun 30, 2010 = × × ×
Mar 31, 2010 = × × ×

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on assets ratio (ROA) over Q4 2014 is the increase in operating profitability measured by EBIT margin ratio.

Disaggregation of Net Profit Margin

Allergan Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2014 = × ×
Sep 30, 2014 = × ×
Jun 30, 2014 = × ×
Mar 31, 2014 = × ×
Dec 31, 2013 = × ×
Sep 30, 2013 = × ×
Jun 30, 2013 = × ×
Mar 31, 2013 = × ×
Dec 31, 2012 = × ×
Sep 30, 2012 = × ×
Jun 30, 2012 = × ×
Mar 31, 2012 = × ×
Dec 31, 2011 = × ×
Sep 30, 2011 = × ×
Jun 30, 2011 = × ×
Mar 31, 2011 = × ×
Dec 31, 2010 = × ×
Sep 30, 2010 = × ×
Jun 30, 2010 = × ×
Mar 31, 2010 = × ×

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in net profit margin ratio over Q4 2014 is the increase in operating profitability measured by EBIT margin ratio.